Regulation 138 Amendment of regulation 173 (exemption for certain radiopharmaceuticals)I1
United Kingdom
In regulation 173(c), F1for “marketing authorisation” substitute “UK marketing authorisation or EU marketing authorisation” .
Annotations
Textual amendments
- F1
Words in reg. 138 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 106
Commencement
- I1
Reg. 138 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1